Approximately 20% of all HIV-1 mother-to-child transmission (MTCT) occurs in utero (IU). In a chronic HIV infection, HIV-1 exists as a complex swarm of genetic variants, and following IU MTCT, viral genomic diversity is restricted through a mechanism that remains to be described. The 5′ U3R region of the HIV-1 long terminal repeat (LTR) contains multiple transcription factor (TF) binding sites and regulates viral transcription. In this study, we tested the hypothesis that sequence polymorphisms in the U3R region of LTR are associated with IU MTCT. To this end, we used single template amplification to isolate 517 U3R sequences from maternal, placental, and infant plasma derived from 17 HIV-infected Malawian women: eight whose infants remained HIV uninfected (NT) and nine whose infants became HIV infected IU. U3R sequences show pairwise diversities ranging from 0.2% to 2.3%. U3R sequences from one participant contained two, three, or four putative NF-κB binding sites. Phylogenetic reconstructions indicated that U3R sequences from eight of nine IU participants were consistent with placental compartmentalization of HIV-1 while only one of eight NT cases was consistent with such compartmentalization. Specific TF sequence polymorphisms were not significantly associated with IU MTCT. To determine if replication efficiency of the U3R sequences was associated with IU MTCT, we cloned 90 U3R sequences and assayed promoter activity in multiple cell lines. Although we observed significant, yet highly variable promoter activity and TAT induction of promoter activity in the cell lines tested, there was no association between measured promoter activity and MTCT status. Thus, we were unable to detect a promoter genotype or phenotype associated with IU MTCT.
Get full access to this article
View all access options for this article.
References
1.
Joint United Task Force on HIV/AIDS (UNAIDS): Together We Will End AIDS, 2012. http://unaids.org.
2.
De CockKM, FowleMG, MercierE, et al.: Prevention of mother-to-child HIV transmission in resource-poor countries: Translating research into policy and practice. JAMA, 2000; 283:1175–1182.
3.
UNAIDS/WHO: AIDS Epidemic Update, 2008. http://unaids.org.
4.
UNICEF: State of the World's Children, 2008. http://unicef.org.
5.
KwiekJJ, RussellES, DangKK, et al.: The molecular epidemiology of HIV-1 envelope diversity during HIV-1 subtype C vertical transmission in Malawian mother-infant pairs. AIDS (London), 2008; 22:863–871.
6.
KrebsFC, HoganTH, QuiterioS, GartnerS, and WigdahlB: Lentiviral LTR-directed expression, sequence variation, and disease pathogenesis. In: HIV Sequence Compendium 2001 (KuikenC, FoleyB, HahnB, MarxP, McCutchanF, MellorsJW, WolinskyS, and KorberB, Eds.). Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, 2001. Los Alamos. 29–70.
7.
HendersonAJ, ZouX, and CalameKL: C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol, 1995; 69:5337.
8.
ShawJP, TooleJJ, EmmelEA, et al.: Identification of a putative regulator of early T cell activation genes. Science (Washington), 1988; 241:202–205.
9.
TesmerVM, RajadhyakshaA, BabinJ, and BinaM: NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1. Proc Natl Acad Sci USA, 1993; 90:7298.
10.
JeeningaRE, HoogenkampM, Armand-UgonM, et al.: Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol, 2000; 74:3740–3751.
11.
GaynorR: Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS, 1992; 6:347.
12.
GarciaJA, HarrichD, SoultanakisE, et al.: Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J, 1989; 8:765.
13.
SethA, HodgeDR, ThompsonDM, et al.: ETS family proteins activate transcription from HIV-1 long terminal repeat. AIDS Res Hum Retroviruses, 1993; 9:1017–1023.
14.
GaoF, RobertsonDL, MorrisonSG, et al.: The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol, 1996; 70:7013–7029.
15.
McNearneyT, HornickovaZ, TempletonA, et al.: Nef and LTR sequence variation from sequentially derived human immunodeficiency virus type 1 isolates. Virology, 1995; 208:388–398.
16.
MichaelNL, D'ArcyL, EhrenbergPK, and RedfieldRR: Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. J Virol, 1994; 68:3163–3174.
17.
MillerCJ: Host and viral factors influencing heterosexual HIV transmission. Rev Reprod, 1998; 3:42–51.
18.
NovitskyVA, MontanoMA, and EssexMAX: Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine. AIDS Res Hum Retroviruses, 1998; 14:1079–1085.
19.
TraskSA, DerdynCA, FideliU, et al.: Molecular epidemiology of human immunodeficiency virus type 1 transmission in a heterosexual cohort of discordant couples in Zambia. J Virol, 2002; 76:397–405.
20.
KokenSEC, Van WamelJLB, GoudsmitJ, BerkhoutB, and GeelentJLMC: Natural variants of the HIV-1 long terminal repeat: Analysis of promoters with duplicated DNA regulatory motifs. Virology, 1992; 191:968–972.
21.
ConnorRI and HoDD: Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol, 1994; 68:4400–4408.
22.
EstableMC, BellB, MerzoukiA, et al.: Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol, 1996; 70:4053–4062.
23.
Gómez-RománVR, VasquezJA, BasualsoMDC, et al.: nef/long terminal repeat quasispecies from HIV type 1-Mexican patients with different progression patterns and their pathogenesis in hu-PBL-SCID mice. AIDS Res Hum Retroviruses, 2000; 16:441–452.
24.
KrebsFC, MehrensD, PomeroyS, GoodenowMM, and WigdahlB: Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes. J Biomed Sci, 1998; 5(1):31–44.
25.
KirchhoffF, GreenoughTC, HamacherM, SullivanJL, and DesrosiersRC: Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat 1 genes derived from individuals with different rates of disease progression. Virology, 1997; 232:319–331.
26.
ZhangL, HuangY, YuanH, et al.: Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection. J Virol, 1997; 71:5608–5613.
27.
RossHL, GartnerS, McArthurJC, et al.: HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. J Neurovirol, 2001; 7:235–249.
28.
BerkhoutB and JeangKT: Functional roles for the TATA promoter and enhancers in basal and Tat-induced expression of the human immunodeficiency virus type 1 long terminal repeat. J Virol, 1992; 66:139.
29.
MingyanY, XinyongL, and De ClercqE: NF-kappaB: The inducible factors of HIV-1 transcription and their inhibitors. Mini Rev Med Chem, 2009; 9:60–69.
30.
NabelG and BaltimoreD: An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature, 1987; 326:711–713.
31.
ZeichnerSL, KimJY, and AlwineJC: Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus type 1 long terminal repeat. J Virol, 1991; 65:2436–2444.
32.
GolubEI, LiGG, and VolskyDJ: Differences in the basal activity of the long terminal repeat determine different replicative capacities of two closely related human immunodeficiency virus type 1 isolates. J Virol, 1990; 64:3654–3660.
33.
KwiekJJ, ArneyLA, HarawaV, et al.: Maternal-fetal DNA admixture is associated with intrapartum mother-to-child transmission of HIV-1 in Blantyre, Malawi. J Infect Dis, 2008; 197:1378–1381.
34.
MwapasaV, RogersonSJ, MolyneuxME, et al.: The effect of Plasmodium falciparum malaria on peripheral and placental HIV-1 RNA concentrations in pregnant Malawian women. AIDS, 2004; 18:1051–1058.
35.
MwapasaV, RogersonSJ, KwiekJJ, et al.: Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi. AIDS, 2006; 20:1869–1877.
36.
KumarSB, HandelmanSK, VoronkinI, et al.: Different regions of HIV-1 subtype C env are associated with placental localization and in utero mother-to-child transmission. J Virol, 2011; 85:7142–7152.
37.
GuayLA, MusokeP, FlemingT, et al.: Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet, 1999; 354:795–802.
38.
BrysonYJ, LuzuriagaK, SullivanJL, and WaraDW: Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med, 1992; 327:1246–1247.
39.
Salazar-GonzalezJF, BailesE, PhamKT, et al.: Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol, 2008; 82:3952–3970.
40.
GoonetillekeN, LiuMK, Salazar-GonzalezJF, et al.: The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med, 2009; 206:1253–1272.
41.
PalmerS, KearneyM, MaldarelliF, et al.: Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis. J Clin Microbiol, 2005; 43:406–413.
42.
SimmondsP, BalfeP, PeuthererJF, et al.: Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol, 1990; 64:864–872.
43.
BellJR: A simple way to treat PCR products prior to sequencing using ExoSAP-IT. Biotechniques, 2008; 44(6):834.
44.
EdgarRC: MUSCLE: Multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res, 2004; 32:1792–1797.
45.
StamatakisA: RAxML-VI-HPC: Maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics, 2006; 22:2688–2690.
46.
DengW, MaustBS, NickleDC, et al.: DIVEIN: A web server to analyze phylogenies, sequence divergence, diversity, and informative sites. Biotechniques, 2010; 48:405.
47.
Salazar-GonzalezJF, SalazarMG, KeeleBF, et al.: Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med, 2009; 206:1273–1289.
48.
MehtaR, RamakrishnanR, DoktorK, et al.: Genetic characterization of HIV type 1 long terminal repeat following vertical transmission. AIDS Res Hum Retroviruses, 2008; 24:437–445.
49.
HerbeckJT, RollandM, LiuY, et al.: Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes. J Virol, 2011; 85:7523–7534.
50.
OchsenbauerC, EdmondsTG, DingH, et al.: Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J Virol, 2012; 86:2715–2728.
51.
PondSL and FrostSD: Datamonkey: Rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics, 2005; 21:2531–2533.
52.
PondSL, FrostSD, and MuseSV: HyPhy: Hypothesis testing using phylogenies. Bioinformatics, 2005; 21:676–679.
53.
SlatkinM and MaddisonWP: A cladistic measure of gene flow inferred from the phylogenies of alleles. Genetics, 1989; 123:603.
54.
HudsonRR: A new statistic for detecting genetic differentiation. Genetics, 2000; 155:2011.
55.
ZarateS, PondSLK, ShapshakP, and FrostSDW: Comparative study of methods for detecting sequence compartmentalization in human immunodeficiency virus type 1. J Virol, 2007; 81:6643.
56.
WuL, MartinTD, CarringtonM, and KewalRamaniVN: Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology, 2004; 318:17–23.
57.
WeissA, WiskocilRL, and StoboJD: The role of T3 surface molecules in the activation of human T cells: A two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J Immunol, 1984; 133:123–128.
58.
DyerBW, FerrerFA, KlinedinstDK, and RodriguezR: A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal Biochem, 2000; 282:158.
59.
LiuSY, ZengFF, and HuangGF: Analysis of human immunodeficiency virus type 1 nef gene sequences among inmates from prisons in China. AIDS Res Hum Retroviruses, 2009; 25:525–529.
60.
HahnT, RamakrishnanR, and AhmadN: Evaluation of genetic diversity of human immunodeficiency virus type 1 nef gene associated with vertical transmission. J Biomed Sci, 2003; 10:436–450.
61.
DelportW, PoonAF, and FrostSD: Datamonkey 2010: A suite of phylogenetic analysis tools for evolutionary biology. Bioinformatics, 2010; 26:2455–2457.
62.
ParrishNF, WilenCB, BanksLB, et al.: Transmitted/founder and chronic subtype C HIV-1 use CD4 and CCR5 receptors with equal efficiency and are not inhibited by blocking the integrin alpha4beta7. PLoS Pathog, 2012; 8(5):e1002686.
63.
ChandeAG, BabaM, and MukhopadhyayaR: A single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation. AIDS Res Hum Retroviruses, 2012; 28:902–906.
64.
RamakrishnanR, LiuH, DonahueH, et al.: Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function. Retrovirology, 2012; 9:90.
65.
MurrellB, WertheimJO, and MoolaS: Detecting individual sites subject to episodic diversifying selection. PLoS Genet, 2012; 8:e1002764.
66.
ArhelNJ and KirchhoffF: Implications of Nef: Host cell interactions in viral persistence and progression to AIDS. Curr Top Microbiol Immunol, 2009; 339:147–175.
67.
PushkerR, JacqueJM, and ShieldsDC: Meta-analysis to test the association of HIV-1 nef amino acid differences and deletions with disease progression. J Virol, 2010; 84:3644–3653.
68.
Kobayashi-IshiharaM, YamagishiM, HaraT, et al.: HIV-1-encoded antisense RNA suppresses viral replication for a prolonged period. Retrovirology, 2012; 9:32.
69.
BenirschkeK, KaufmannP, and BaergenRN: Pathology of the Human Placenta, 5th ed. Springer, New York, 2006.
70.
PetitoCK: Human immunodeficiency virus type 1 compartmentalization in the central nervous system. J Neurovirol, 2004; 10:21–24.
71.
RitolaK, RobertsonK, FiscusSA, HallC, and SwanstromR: Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia. J Virol, 2005; 79:10830–10834.
72.
MarrasD, BruggemanLA, GaoF, et al.: Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med, 2002; 8:522–526.
73.
CoombsRW, SpeckCE, HughesJP, et al.: Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: Evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis, 1998; 177:320.
74.
MenuE, KeouFXM, LagayeS, et al.: Selection of maternal human immunodeficiency virus type 1 variants in human placenta. J Infect Dis, 1999; 179:44–51.
75.
SalemiM, LamersSL, HuysentruytLC, et al.: Distinct patterns of HIV-1 evolution within metastatic tissues in patients with non-Hodgkins lymphoma. PloS One, 2009; 4:e8153.
76.
BecquartP, ChomontN, RoquesP, et al.: Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers. Virology, 2002; 300:109–117.
77.
KourtisAP, ButeraS, IbegbuC, BelecL, and DuerrA: Breast milk and HIV-1: Vector of transmission or vehicle of protection?. Lancet Infect Dis, 2003; 3:786–793.
78.
PriceDH: P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol, 2000; 20:2629.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
